The accumulation of effector immune cells such as DCs and CD8+ T lymphocytes into primary tumour lesions is associated with prolonged survival and a reduced incidence of metastases in patients with several types of solid cancer, including primary cutaneous melanomas [47, 48]. This evidence concerns the gene CD8A and neoplasm.